$ Value
$0
Shares
28,250
Price
$0
Filed
Feb 18
Insider
Name
Muir Kevin
Title
GM INTERVENTIONAL ONCOLOGY
CIK
0001929335
Roles
Transaction Details
Transaction Date
2026-02-17
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
28,250
Footnotes
The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 17, 2026 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. | Represents an RSU award, one-third of which shall vest on February 17, 2027 with the remaining 2/3 two-thirds of the RSUs vesting in equal annual installments over the following two years. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date.
Filing Info
Other Insiders at DCTH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
MICHEL GERARD J
CHIEF EXECUTIVE OFFICER
|
$100K | — | 2026-03-02 |
|
Pennell Sandra
Chief Financial Officer
|
$50K | — | 2026-03-06 |
|
Vukovic Vojo
CHIEF MEDICAL OFFICER
|
— | — | 2026-02-17 |
|
Muir Kevin
GM INTERVENTIONAL ONCOLOGY
|
— | — | 2026-02-17 |
|
Hoffman David L.
GEN'L COUNSEL, CCO & SECY
|
— | — | 2026-02-17 |
|
Rook Martha S.
CHIEF OPERATING OFFICER
|
— | — | 2026-02-17 |